Emily Becker, MD, discusses the role of AhR agonists, skin barrier function, and steroid-free treatment options for pediatric atopic dermatitis.
News|Articles|July 4, 2025
Advancing pediatric health: Key updates and clinical insights from the first half of 2025
Author(s)Morgan Ebert, Executive Editor
Fact checked by: Joshua Fitch, Senior Editor
A look back at the most important FDA approvals, clinical research, and expert perspectives shaping pediatric health care in the first half of 2025.
Advertisement
Advertisement
The first half of 2025 has been marked by significant regulatory milestones in pediatric medicine, with the FDA advancing new therapies, diagnostic tools, and preventive strategies across a range of conditions affecting children and adolescents.
Related to this article
Post hoc data show cariprazine improved both manic and depressive symptoms through 52 weeks in youth aged 10 to 17 years with bipolar I disorder.
CDC data show pediatric CP-CRE incidence rose 92% from 2019 to 2024, driven by NDM-CRE, mostly in children with complex medical needs.
Julie Sweetland, PhD, shares strategies to improve vaccine conversations by explaining the science, acknowledging parental concerns, and building trust.
A meta-analysis of 52 studies links NO2, SO2, and particulate matter to more pediatric atopic dermatitis visits and higher prevalence.
FDA is investigating tumor reports after Zolgensma for SMA, including 2 confirmed cases of vector integration near the GLI1 oncogene.
Jon Matthew Farber, MD, shares his thoughts on the use of noninvasive brain stimulation for ADHD.
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Advertisement
Advertisement